If some form of Most Favored Nation drug pricing is adopted in the US, how far prices fall, how many patients gain access, and which patients they are depends on the strategic responses of ...
The Trump Administration has designed a Most-Favored-Nation (MFN) drug pricing policy framework to address the major differences in drug prices and contributions to the pharmaceutical innovation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results